Suppr超能文献

大麻污染物限制了大麻二酚的药理学应用。

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol.

作者信息

Montoya Zackary, Conroy Matthieu, Vanden Heuvel Brian D, Pauli Christopher S, Park Sang-Hyuck

机构信息

Institute of Cannabis Research, Colorado State University-Pueblo, Pueblo, CO, United States.

Department of Biology, Colorado State University-Pueblo, Pueblo, CO, United States.

出版信息

Front Pharmacol. 2020 Sep 11;11:571832. doi: 10.3389/fphar.2020.571832. eCollection 2020.

Abstract

For nearly a century, has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in due to the therapeutic potential of phytocannabinoids. With this emerging interest in , concerns have arisen about the possible contaminations of hemp with pesticides, heavy metals, microbial pathogens, and carcinogenic compounds during the cultivation, manufacturing, and packaging processes. This is of particular concern for those turning to for medicinal purposes, especially those with compromised immune systems. This review aims to provide types of contaminants and examples of contamination using case studies that elucidate the medical consequences consumers risk when using adulterated products. Thus, it is imperative to develop universal standards for cultivation and testing of products to protect those who consume .

摘要

近一个世纪以来,在全球范围内一直被污名化且被定为犯罪行为,但近年来,由于植物大麻素的治疗潜力,人们对其兴趣日益浓厚。随着对大麻兴趣的不断涌现,人们开始担心在种植、制造和包装过程中大麻可能受到农药、重金属、微生物病原体和致癌化合物的污染。这对于那些将大麻用于医疗目的的人,尤其是免疫系统受损的人来说,尤为令人担忧。本综述旨在通过案例研究提供污染物类型和大麻污染的例子,以阐明消费者使用掺假大麻产品时面临的医疗后果风险。因此,制定产品种植和检测的通用标准以保护大麻消费者势在必行。

相似文献

1
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol.大麻污染物限制了大麻二酚的药理学应用。
Front Pharmacol. 2020 Sep 11;11:571832. doi: 10.3389/fphar.2020.571832. eCollection 2020.
2
[New targeted compounds-biosynthesis of phytocannabinoids].[新型靶向化合物——植物大麻素的生物合成]
Sheng Wu Gong Cheng Xue Bao. 2021 Jun 25;37(6):1968-1985. doi: 10.13345/j.cjb.200453.
8
(Hemp) Seeds, Δ-Tetrahydrocannabinol, and Potential Overdose.(大麻)种子、Δ-四氢大麻酚与潜在的过量摄入
Cannabis Cannabinoid Res. 2017 Oct 1;2(1):274-281. doi: 10.1089/can.2017.0040. eCollection 2017.

引用本文的文献

6
The Exploration of Cannabis and Cannabinoid Therapies for Migraine.大麻和大麻素疗法治疗偏头痛的探索。
Curr Pain Headache Rep. 2023 Sep;27(9):339-350. doi: 10.1007/s11916-023-01144-z. Epub 2023 Jul 29.

本文引用的文献

1
The Trouble with CBD Oil.大麻二酚(CBD)油的问题。
Med Cannabis Cannabinoids. 2018 Jun 12;1(1):65-72. doi: 10.1159/000489287. eCollection 2018 Jun.
2
Labeling of Cannabidiol Products: A Public Health Perspective.大麻二酚产品的标签:公共卫生视角
Cannabis Cannabinoid Res. 2020 Dec 15;5(4):274-278. doi: 10.1089/can.2019.0101. eCollection 2020.
5
Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes.医用大麻花:USP 质量属性考量。
J Nat Prod. 2020 Apr 24;83(4):1334-1351. doi: 10.1021/acs.jnatprod.9b01200. Epub 2020 Apr 13.
6
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects.大麻二酚药物的临床试验结果与不良反应
Front Pharmacol. 2020 Feb 25;11:63. doi: 10.3389/fphar.2020.00063. eCollection 2020.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验